Cargando…
Fine-tuned continuous renal replacement therapy with calcium-free dialysate to manage severe hypercalcemia refractory to medical and intermittent hemodialysis
Malignancy-related hypercalcemia is a leading cause of hypercalcemia among hospitalized patients that carries poor prognosis. Parathyroid carcinoma is a rare form of primary hyperparathyroidism that may be associated with PTH dependent hypercalcemia. Severe hypercalcemia is life-threatening and may...
Autores principales: | Scheen, Marc, Nowak, Grzegorz, Sanchez, Bienvenido, Teta, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178807/ https://www.ncbi.nlm.nih.gov/pubmed/35676731 http://dx.doi.org/10.1186/s40001-022-00715-x |
Ejemplares similares
-
Impact of Dialysate Calcium Concentration on Clinical Outcomes in Incident Hemodialysis Patients
por: Kim, Hyung Wook, et al.
Publicado: (2015) -
The Use of Hemodialysis in Refractory Hypercalcemia Secondary to Parathyroid Carcinoma
por: Loh, Huai Heng, et al.
Publicado: (2014) -
Calcium Repletion and Regional Citrate Anticoagulation in Hemodialysis and Hemodiafiltration: Using Dialysate Calcium to Modify Hypocalcemia
por: Dorie, Justin R., et al.
Publicado: (2021) -
Effects of Lowering Dialysate Calcium Concentrations on Arterial Stiffness in Patients Undergoing Hemodialysis
por: Kim, Jwa-Kyung, et al.
Publicado: (2011) -
Low calcium dialysate combined with CaCO(3) in hyperphosphatemia in hemodialysis patients
por: GAO, ZHUO, et al.
Publicado: (2013)